... with the α(1)-blocker alfuzosin in outflow obstruction of patients with symptomatic benign prostatic hyperplasia (BPH). Material and Methods: Urodynamic pressure/flow parameters were assessed after 2 weeks of placebo run-in,4 weeks of placebo (47 patients) or 2.5 mg t.i.d. alfuzosin treatment (47 patients...

... of a Simple Home Flow Test as a Quality Indicator for Male Patients Treated for Lower Urinary Tract Symptoms Suggestive of Bladder Outlet Obstruction Key Words Flowmetry Home flow test Quality indicator Benign prostatic hyperplasia Abstract Objective: To evaluate the performance of a simple home flow test...

...B. Lukacs Treatment utility can be defined as a combination of objective clinical efficacy and quality-of-life results (i.e. subjective criteria). It is a particularly useful concept in diseases such as benign prostatic hyperplasia where important differences may exist between the results...

...M. O’Leary Measurement of lower urinary tract symptoms in patients with benign prostatic hyperplasia (BPH) is extremely important as it is these symptoms which account for much of the morbidity associated with this disease. The symptoms of BPH interfere with factors affecting the patient’s health...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Benign prostatic hyperplasia Quality of life Questionnaires Linguistic Cultural validation European Urology Peter Boyle Milan, Italy Eur Urol 1997;32(suppl 2):50-52...

...R. Hartung Ideally, a decision analysis should be performed in order to provide patient information and enhance decision-making procedures in benign prostatic hyperplasia (BPH). The steps associated with a decision analysis include creating a decision tree, identifying decision alternatives...

...Hans Mensink Treatment evaluation in benign prostatic hyperplasia (BPH) is complicated by a number of interdependent factors. The evaluation of the individual patient is influenced by the riskibenefit ratio and health related quality of life and this,in turn, is interrelated with the evaluation...

...F. Calais Da Silva The epidemiology and natural evolution of benign prostatic hyperplasia(BPH) are important when considering the topic of natural evolution versus medical treatment. The incidence of BPH increases with age; it is thought that about 75% of men over 50 years of age suffer from some...

...Mehmet Cemil Uygur; Demokan Erol; Mesut Çetinkaya; Yücel Güngen; Yahya Laleli; Uğur Altuğ Objective: To analyze serum prostate-specific antigen (PSA) levels of men proven to have benign prostatic hyperplasia (BPH) and to document any correlation between PSA, age and resected or enucleated prostate...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Thermotherapy Benign prostatic hyperplasia Non-surgical therapy of BPH European Urology Clinical Paper Eur Urol 1997;32:198-208 1617527 B. Mauroya M. Chivea X. Stefaniaka D...

...Feridun Sengör; Kubilay Erdogan; Deniz Tuzluoglu; Serhat Onur; Ali Erol; Tuncay Sözer Objective: This study was performed to evaluate safety and efficacy of laser prostatectomy in the treatment of symptomatic benign prostatic hyperplasia(BPH). Methods: Neodymium:yttrium-aluminum-gamet (YAG) visual...

...Michele Gallucci; Paolo Puppo; Pasquale Fortunato; Marcello Mauro; Andrea Vincenzoni; Antonio Zaccara Transurethral resection of the prostate (TURP) is still considered the ‘gold standard’ in the treatment of benign prostatic hyperplasia (BPH). However, it is possible to replace this technique...

...J.M. Buzelin; S. Roth; C. Geffriaud-Ricouard; M.C. Delàuche-Cavailier; and the ALGEBI Study Group Objectives: To assess the efficacy and safety of a sustained-release (SR) formulation of alfuzosin, a selective ai-blocker, in patients with symptomatic benign prostatic hyperplasia (BPH). Methods...

... inhibitor, in 2 previously reported groups of patients with symptomatic benign prostatic hyperplasia (BPH). Prostate volume was measured by magnetic resonance imaging, and the maximum urinary flow rate was assessed noninvasively. Symptoms were scored utilizing a patient self-administered symptom score...

...F.J. Fowler In the United States, prostate surgery, most often transurethral resection of the prostate, is a common treatment for men with benign prostatic hyperplasia. For at least 80% of patients, this elective surgery reduces everyday symptoms associated with urination, and reduces the risk...

...L. Boccon-Gibod With the advent of new treatments for benign prostatic hyperplasia (BPH), the urologist must objectively assess the results of new and traditional therapeutic options. This requires three sets of data - not all of which may be readily available - including a precise knowledge...

... Benign prostatic hyperplasia Finasteride Eur Urol 1991;20(suppl 2)'82-86 © 1991 Karger AG, Basel 0302-2838/91/0206-0082 $ 2.73/0 Hormonal Effects of a 5a-Reductase Inhibitor (Finasteride) on Hormonal Levels in Normal Men and in Patients with Benign Prostatic Hyperplasia A. Vermeulena, V. A. GiagullïP...

...F. Pagano; F. Zattoni; F. Vianello; R. Piazza; G. Capitanio No definite relationship can be demonstrated between benign prostatic hyperplasia (BPH) and prostatic cancer on the basis of various anatomic and morphologic features. However, interesting recent observations suggest a link between BPH...

...J.T. Andersen Considerable new knowledge about benign prostatic hyperplasia has been gained over the past two decades,particularly with regard to its natural history, hydrodynamic changes in the lower urinary tract, and the symptomatic and urodynamic results of treatment. A survey of the literature...

...P. Boyle; R. McGinn; P. Maisonneuve; C. La Vecchia Despite being such a common condition, morphologically prevalent in 88% of autopsies of old (>80 years) men, little epidemiologic research has been undertaken on benign prostatic hyperplasia (BPH). The prevalence of BPH, and probably...